<!DOCTYPE html>
<html>
<header>
</header>

<body>
    <div class="container" style="text-align:left;">
        <div style="text-align:center;">
            <!-- <iframe width="900" height="800" frameborder="0" scrolling="no" src="//plotly.com/~hzha0119/56.embed?modebar=false&link=false"></iframe> -->
            <iframe width="1000" height="800" frameborder="0" scrolling="no" src="//plotly.com/~hzha0119/70.embed?modebar=false&link=false"></iframe>
        </div>
        <div>
            <h3>Caveats/footnotes:</h3>
            <ul>
                <li>High-grade abnormality detection is defined as the number of women who have a high-grade abnormality detected per 1,000 women screened; a high-grade abnormality is defined as a histology result of HS03 (CIN NOS, CIN II and CIN III) or HE03 (endocervical dysplasia and adenocarcinoma in situ).</li>																				
                <li>Data are based on all women screened in each jurisdiction.</li>
                <li>These data exclude women who have opted off the cervical screening register.</li>
                <li>Periods based on calendar years (1 January to 31 December).</li>
                <li>Source: AIHW 2018. Cervical screening in Australia 2018. Cat. no. CAN 111. Canberra: AIHW.</li>
            </ul>
        </div>
    </div>
</body>

</html>